Literature DB >> 28067429

Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.

David J Olivos1,2, Marta Alvarez1, Ying-Hua Cheng1, Richard Adam Hooker1, Wendy A Ciovacco1,3, Monique Bethel1, Haley McGough1, Christopher Yim1, Brahmananda R Chitteti4, Pierre P Eleniste5, Mark C Horowitz3, Edward F Srour2,4,6, Angela Bruzzaniti5, Robyn K Fuchs7, Melissa A Kacena1,3.   

Abstract

The Lnk adapter protein negatively regulates the signaling of thrombopoietin (TPO), the main megakaryocyte (MK) growth factor. Lnk-deficient (-/-) mice have increased TPO signaling and increased MK number. Interestingly, several mouse models exist in which increased MK number leads to a high bone mass phenotype. Here we report the bone phenotype of these mice. MicroCT and static histomorphometric analyses at 20 weeks showed the distal femur of Lnk-/- mice to have significantly higher bone volume fraction and trabecular number compared to wild-type (WT) mice. Notably, despite a significant increase in the number of osteoclasts (OC), and decreased bone formation rate in Lnk-/- mice compared to WT mice, Lnk-/- mice demonstrated a 2.5-fold greater BV/TV suggesting impaired OC function in vivo. Additionally, Lnk-/- mouse femurs exhibited non-significant increases in mid-shaft cross-sectional area, yet increased periosteal BFR compared to WT femurs was observed. Lnk-/- femurs also had non-significant increases in polar moment of inertia and decreased cortical bone area and thickness, resulting in reduced bone stiffness, modulus, and strength compared to WT femurs. Of note, Lnk is expressed by OC lineage cells and when Lnk-/- OC progenitors are cultured in the presence of TPO, significantly more OC are observed than in WT cultures. Lnk is also expressed in osteoblast (OB) cells and in vitro reduced alkaline phosphatase activity was observed in Lnk-/- cultures. These data suggest that both direct effects on OB and OC as well as indirect effects of MK in regulating OB contributes to the observed high bone mass. J. Cell. Biochem. 118: 2231-2240, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  BONE MASS; BONE PHENOTYPE; LNK; MEGAKARYOCYTES; OSTEOBLASTS; OSTEOCLASTS

Mesh:

Substances:

Year:  2017        PMID: 28067429      PMCID: PMC5562279          DOI: 10.1002/jcb.25874

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  46 in total

1.  Thrombopoietin inhibits in vitro osteoclastogenesis from murine bone marrow cells.

Authors:  T Wakikawa; A Shioi; M Hino; M Inaba; Y Nishizawa; N Tatsumi; H Morii; S Otani
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice.

Authors:  J L Villeval; K Cohen-Solal; M Tulliez; S Giraudier; J Guichard; S A Burstein; E M Cramer; W Vainchenker; F Wendling
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

3.  Characterization of osteocrin expression in human bone.

Authors:  Sharyn Bord; Deborah C Ireland; Pierre Moffatt; Gethin P Thomas; Juliet E Compston
Journal:  J Histochem Cytochem       Date:  2005-05-27       Impact factor: 2.479

4.  Formation of bone by isolated, cultured osteoblasts in millipore diffusion chambers.

Authors:  D J Simmons; G N Kent; R L Jilka; D M Scott; M Fallon; D V Cohn
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

5.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

6.  The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation.

Authors:  Wendy A Ciovacco; Carolyn G Goldberg; Amanda F Taylor; Justin M Lemieux; Mark C Horowitz; Henry J Donahue; Melissa A Kacena
Journal:  Bone       Date:  2008-09-10       Impact factor: 4.398

7.  Signaling pathways involved in megakaryocyte-mediated proliferation of osteoblast lineage cells.

Authors:  Ying-Hua Cheng; Drew A Streicher; David L Waning; Brahmananda R Chitteti; Rita Gerard-O'Riley; Mark C Horowitz; Joseph P Bidwell; Fredrick M Pavalko; Edward F Srour; Lindsey D Mayo; Melissa A Kacena
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

8.  Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease.

Authors:  Larry J Suva; Eric Hartman; Joshua D Dilley; Susan Russell; Nisreen S Akel; Robert A Skinner; William R Hogue; Ulrich Budde; Kottayil I Varughese; Taisuke Kanaji; Jerry Ware
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

9.  Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice.

Authors:  X Q Yan; D Lacey; F Fletcher; C Hartley; P McElroy; Y Sun; M Xia; S Mu; C Saris; D Hill; R G Hawley; I K McNiece
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

10.  The effects of three different demineralization agents on osteopontin localization in adult rat bone using immunohistochemistry.

Authors:  J D Frank; R Balena; P Masarachia; J G Seedor; M E Cartwright
Journal:  Histochemistry       Date:  1993-04
View more
  6 in total

1.  Aging negatively impacts the ability of megakaryocytes to stimulate osteoblast proliferation and bone mass.

Authors:  Kevin A Maupin; Evan R Himes; Artur P Plett; Hui Lin Chua; Pratibha Singh; Joydeep Ghosh; Safa F Mohamad; Irushi Abeysekera; Alexa Fisher; Carol Sampson; Jung-Min Hong; Paul Childress; Marta Alvarez; Edward F Srour; Angela Bruzzaniti; Louis M Pelus; Christie M Orschell; Melissa A Kacena
Journal:  Bone       Date:  2019-07-09       Impact factor: 4.398

2.  Megakaryocyte and Osteoblast Interactions Modulate Bone Mass and Hematopoiesis.

Authors:  Marta B Alvarez; LinLin Xu; Paul J Childress; Kevin A Maupin; Safa F Mohamad; Brahmananda R Chitteti; Evan Himes; David J Olivos; Ying-Hua Cheng; Simon J Conway; Edward F Srour; Melissa A Kacena
Journal:  Stem Cells Dev       Date:  2018-05-15       Impact factor: 3.272

3.  LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway.

Authors:  Jianxin Lv; Wei Yu; Yanan Zhang; Xinhua Cao; Lifei Han; Haolin Hu; Chenfei Wang
Journal:  Cancer Cell Int       Date:  2020-04-15       Impact factor: 5.722

4.  Megakaryocytes promote osteoclastogenesis in aging.

Authors:  Deepa Kanagasabapathy; Rachel J Blosser; Kevin A Maupin; Jung Min Hong; Marta Alvarez; Joydeep Ghosh; Safa F Mohamad; Alexandra Aguilar-Perez; Edward F Srour; Melissa A Kacena; Angela Bruzzaniti
Journal:  Aging (Albany NY)       Date:  2020-07-07       Impact factor: 5.682

Review 5.  Craniofacial Bone Tissue Engineering: Current Approaches and Potential Therapy.

Authors:  Arbi Aghali
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

6.  Inhibition of Osteoblast Differentiation by JAK2V617F Megakaryocytes Derived From Male Mice With Primary Myelofibrosis.

Authors:  Aikaterini Karagianni; Shinobu Matsuura; Louis C Gerstenfeld; Katya Ravid
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.